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Abstract Four 12.2-12.6 kDa small heat-shock proteins 
(sHSPs) of Caenorhabditis elegans are the smallest known 
members of the sHSP family. They essentially comprise the 
characteristic C-terminal 'ct-crystallin domain' of the sHSPs, 
having a very short N-terminal region, and lacking a C-terminal 
tail. Recombinant Hspl2.2 and 12.3 are characterized here. Far- 
UV CD spectra reveal, as for other sHSPs, predominantly a [~- 
sheet structure. By gel permeation and crosslinking, they are the 
first sHSPs shown to occur as tetramers, rather than forming the 
usual large multimeric complexes. Exceptionally, too, both 
appear devoid of in vitro chaperone-like abilities. This supports 
the notion that tetramers are the building blocks of sHSP 
complexes, and that higher multimer formation, mediated 
through the N-terminal domains, is a prerequisite for chaper- 
one-like activity. 
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Key words." Small heat-shock protein; Molecular chaperone; 
Caenorhabditis elegans 
I. Introduction 
Small heat-shock proteins (sHSPs) are present in all organ- 
isms studied, and form a diverse family of proteins with sub- 
unit molecular masses ranging from 12 to 43 kDa (for recent 
reviews, see [1 3]). Many of them are constitutively expressed, 
often developmentally regulated and reaching very high levels, 
while others are induced under various stress conditions. 
Overexpression of sHSPs in cultured cells confers thermotol- 
erance [4]. The mechanism of this protective effect is un- 
known, but is likely to depend on the chaperone-like activity 
of the sHSPs [5], that is their ATP-independent cal~acity to 
prevent the aggregation of denaturing proteins. By stably 
binding misfolded proteins in the cell, the sHSPs may create 
a reservoir of non-native proteins that can be refolded to the 
native state, probably in cooperation with other, ATP-de- 
pendent molecular chaperones [6-8]. 
Structurally, the sHSP subunits are thought o consist of an 
N-terminal domain, which is variable in sequence and length, 
and an  evolutionarily conserved C-terminal or 'c~-crystallin' 
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domain which terminates in a short and flexible C-terminal 
tail [3,9,10]. Subunits generally assemble into large heteroge- 
neous complexes (150-800 kDa), possibly in a flexible micelle- 
like arrangement, with the hydrophobic N-terminal domains 
directed inward, and the polar C-terminal domains and tails 
extending into solution [11 14]. Preliminary X-ray crystallo- 
graphic data of the 16.5 kDa sHSP of the archaebacterium 
Methanococcusjannaschii is now available [15]. It reveals a 24 
subunit octahedral complex, formed by rotation around a 
threefold crystallographic axis of eight subunits in an asym- 
metric unit. Recently, too, cryo-electron microscopic studies 
have shown that aB-crystallin, a major vertebrate sHSP, 
forms roughly spherical 8 18 nm asymmetric complexes con- 
taining a large 3 10 nm cavity [16]. 
It is reasonable to assume that clues for the common struc- 
tural and functional features of the sHSP family can be found 
in their conserved 80 100 residue e~-crystallin domain, where- 
as the variable N-terminal domain and C-terminal tail mod- 
ulate the specific properties of each individual type of sHSP. 
In that respect he four 12 kDa sHSPs of Caenorhabditis ele- 
gans are of special interest. These are the smallest known 
representatives of the family, essentially reduced to the core 
c~-crystallin domain [3,17,18]. Their N-terminal 'domains' 
comprise a mere 25 26 residues, and C-terminal tails are al- 
together lacking. Surprisingly, one of these sHSPs from C. 
elegans, Hspl2.6, was recently reported to be monomeric 
and devoid of chaperone activity [18]. To further explore these 
prototypic sHSPs, we now characterized C. elegans Hspl2.2 
and Hspl2.3, which are the most divergent of the four, dis- 
playing only 43% sequence identity. 
2. Materials and methods 
2.1. Chining, expression and purification o[' Hspl2.2 and Hspl2.3 
eDNA of Hspl2.2, designated as CI4B9.1 in the C. elegans chro- 
mosome III sequencing project [18] (accession umber L15181), was 
amplified from a mixed-stage cDNA library [19], using the 5' primer 
5':GGAATTCCATATGTCCGCTATCGAGGTGAC-3' (EcoRl and 
Ndel sites underlined and bold, respectively) and the 3' primer 5'- 
ATCTGGGATCCTTAAGCCTTCTTGGAAGCAG-3' (BamH1 site 
underlined). The cDNA was subcloned into the EcoRI-BamHI di- 
gested pGEM7Zf(+) vector, sequenced and subsequently cloned into 
the Ndel-BamHI digested pET3a expression vector. Hspl2.3 (acces- 
sion number Z68342 [18]) was amplified using the 5' primer 5'-AGT- 
CATATGTCTGTTGCTATTGATCAC-3' (NdeI site in bold) and the 
3' primer 5'-GCTGGATCCTTACTTTTTCTTGTTTCCGGAGA- 
TGTG-3' (BamHI site underlined), and cloned into a modified 
pRSET A vector lacking the polyhistidine tag, as described earlier 
[18]. The expression vectors containing Hspl2.2 and Hspl2.3 cDNA 
were transformed into Escherichia coli strains BL21(DE3)pLysS and 
BL21(DE3), respectively. Induction, cell lysis, and fractionation were 
essentially performed as described by Merck et al. [20]. Recombinant 
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Hspl2.2 (rec-Hspl2.2) was largely present in the soluble fraction, and 
purified over a Fast Flow DEAE-Sepharose anion exchange column 
(Pharmacia-LKB), eluted with TENs0 buffer, pH 7.7. Rec-Hspl2.2 
was present in the flow-through. Fractions containing rec-Hspl2.2 
were pooled, concentrated and stored at 4°C in the presence of 
0.05% NAN:3. Purification of recombinant Hspl2.3 (rec-Hspl2.3) 
was essentially as described for rec-Hspl2.6 by Leroux et ah [18]. 
Since rec-Hspl2.2 and rec-Hspl2.3 were not sequenced, it remains 
uncertain whether the N-terminal methionine is still present. 
2.2. Circular diehroism ~peetroseopy and heat stability measurement 
Circular dichroism spectra were obtained on a Jasco J-715 spectro- 
polarimeter. Spectra shown are the average of four scans with a scan 
rate of 20 nm/min and a quartz cell length of 1 ram. Experiments were 
performed using a protein concentration of 250 ~tg/ml in 0.1 M 
Na2SO~, 20 mM NaPi, pH 6.9 (SP buffer) at 20°C. Native rec- 
Hspl2.2 and rec-Hspl2.3 were diluted with SP buffer to a final con- 
centration of 0.5 mg/mh Temperature was raised (l°C/min) and ab- 
sorption at 360 nm was measured every 30 s, using a Perkin-Elmer 
Lambda 2 UWVis spectrophotometer connected to a thermostatted 
circulation waterbath and a thermocouple to register the sample tem- 
perature., 
2.3. Size exclusion chromatography and erosslinking qf ree-Hspl2.2 
and ree-Hspl2.3 
The complex size of native and crosslinked rec-Hspl2.2 was deter- 
mined using an LKB Bromma HPLC system in conjunction with a 
Superose 12 HR 10/30 prepacked size exclusion column (30× 1 cm, 
Pharmacia-LKB). Protein samples were 0.2 mg in 1 ml of SP buffer. 
Elution was performed in the same buffer, at a flow rate of 0.5 ml/ 
min, and absorbance was measured at 278 nm. Fractions were ana- 
lyzed by SDS-PAGE [21]. The size of rec-Hspl2.3 was estimated by 
chromatography over a 100× 1.5 cm Sephacryl S-200 HR column, as 
described in [18]. Crosslinking of rec-Hspl2.2 was performed as de- 
scribed by Siezen et al. [22] with minor modifications. The homobi- 
functional crosslinker dimethylsuberimidate (5 mM) was used, with 
100 ~g/ml rec-Hspl2.2 and 10 mM dithiothreitol (DTT) in 0.2 M 
triethanolamine, pH 8,0. Total volume was 2 mh The reaction was 
stopped after 2 h at room temperature by adding glycine up to a final 
concentration of 50 raM. Crosslinking of 1 gM rec-Hspl2.3 with 
2 mM bis(sulfosuccinimidyl)suberate w s carried out in the presence 
or absence of 16 ~tM bovine serum albumin (BSA) and the reaction 
products detected by Western blot analysis with an anti-Hspl2.6 poly- 
clonal antiserum [18]. 
2.4. Chaperone ass~o's 
Two methods were used to assess the capacity of rec-Hspl2.2 and 
rec-Hspl2.3 to protect unfolding proteins from aggregating. In the 
insulin-protection assay [23], different amounts rec-Hspl2.2 and rec- 
Hspl2.3 were incubated with 250 gg bovine pancreas insulin (Sigma) 
at 40°C for 5 rain, in a total volume of 0.98 ml SP buffer. Denatura- 
tion of insulin was then induced by adding 20 gl 1 M DTT, and 
turbidity was measured at 360 nm for 15 min at 40°C, as described 
above. In the citrate synthase assay [6], various amounts of rec- 
Hspl2.2 and rec-Hspl2.3 were incubated for 5 min at 43°C in a 
volume of 2 ml 40 mM HEPES-KOH, pH 7.5. Citrate synthase 
(Boehringer) was then added to a final concentration of 75 riM, and 
scattering was measured on a Hitachi F-3000 spectrofluorimeter ( x- 
citation and emission wavelengths 500 nm; band width 3 nm; 
equipped with a circulating thermostatted waterbath) at 43°C for 15 
min. 
3. Results and discussion 
3.1. Ls'olation, secondary structure, and stability q/rec-Hspl2.2 
and rec-Hspl2.3 
To obtain pure recombinant rec-Hspl2.2 and rec-Hspl2.3 
proteins, the respective cDNAs were amplified with specific 
primers from mixed-stage C. elegans cDNA libraries, and 
cloned into vectors for expression in E. coli. Both proteins 
were found in the soluble fraction of the bacterial lysate, 
a l though rec-Hspl2.2 was also partially present in the insolu- 
ble pellet. The proteins were isolated from the soluble frac- 
tion, and purified to near-homogeneity ( > 95%). Proper fold- 
ing of the recombinant proteins was confirmed by far-UV 
circular dichroism spectroscopy (Fig. IA). The spectra for 
rec-Hspl2.2 and rec-Hspl2.3 both have negative ellipticity, 
with minima at approximately 215 nm and 218 nm, respec- 
tively, which is typical for [g-sheet structure, These results are 
in agreement with secondary structure predictions made for 
Hspl2.2 and Hspl2.3 [18], and are comparable to the far-UV 
CD spectra observed for other sHSPs [1,2]. 
The partial presence of rec-Hspl2.2 in the insoluble fraction 
after expression in E. coli might indicate a lower stability as 
compared to rec-Hspl2.3. We therefore determined the ther- 
mostabil ity of rec-Hspl2.2 and rec-Hspl2.3 by incubating 
them at increasing temperatures in a thermostatted UV/VIS- 
spectrophotometer, and measuring the turbidity at 360 nm 
(Fig. I B). While rec-Hspl2.3 remained stable at temperatures 
as high as 65°C for more than 30 min, rec-Hspl2.2 came fully 
out of solution around 55°C. A far-UV CD spectrum of heat- 
treated rec-Hspl2.3 (Fig. I A) showed that only minor irrever- 
sible changes in secondary structure had occurred after heat- 
ing for 30 min at 65°C. 
3.2. Rec-Hspl2.2 and rec-Hspl2.3 Jorm tetramers 
Size exclusion chromatography showed that rec-Hspl2.3 
eluted as a rather broad peak, indicative of some size hetero- 
geneity, centered around an estimated mass of 39 kDa (Fig. 
2A). A similar result was obtained for rec-Hspl2.2 (see Fig. 
2C). These masses would suggest a trimeric structure, which is 
unexpected because all other sHSPs, with the exception of the 
related Hspl2.6 [18], form much larger complexes. To estab- 
lish the actual number of subunits in the oligomers of rec- 
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Fig. 1. A: Far-UV circular dichroism spectra of rec-Hspl2.2, rec- 
Hspl2.3, and rec-Hspl2.3 after heating for 30 min at 65°C. B: 
Thermostability of rec-Hspl2.2 and rec-Hspl2.3, monitored by 
measuring the turbidity at 360 nm. 
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Hspl2.2 and rec-Hspl2.3, we treated them with the homo- 
bifunctional crosslinking agents dimethylsuberimidate and 
bis(sulfosuccinimidyl)suberate, respectively. Crosslinking of 
rec-Hspl2.3 yielded mainly dimers, some trimers and a het- 
erogeneous group of tetramer-like bands (Fig. 2B, lane 1). In 
the presence of 10-fold excess BSA, to avoid non-specific 
crosslinking, the trimers decreased and the tetramer became 
more homogeneous (Fig. 2B, lane 2). In the case of rec- 
Hspl2.2, crosslinked imers, trimers and tetramers were all 
obtained at higher levels (see Fig. 2C). 
The trimer-like lution of rec-Hspl2.2 and 12.3 during size 
exclusion chromatography might reflect an equilibrium be- 
tween tetramers, trimers, dimers and even monomers. In 
that case, one would expect that the covalently crosslinked 
tetramers elute earlier than the trimers or dimers. Crosslinked 
rec-Hspl2.2 was therefore applied onto a Superose 12 column. 
Again, a single homogeneous peak was obtained, eluting at a 
position corresponding to the estimated mass of a trimer (36 
kDa) (Fig. 2C). SDS-PAGE showed that all three crosslinking 
products were present over the width of the peak, with tet- 
ramers somewhat more abundant in the earlier fractions, and 
monomers in the last eluting fractions (Fig. 2C). Since the 
actual mass of covalently crosslinked tetrameric rec-Hspl2.2 
necessarily is 48.9 kDa, it appears that the oligomer size of 
rec-Hspl2.2 cannot accurately be estimated by size exclusion 
chromatography. We conclude that rec-Hspl2.2 and rec- 
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Fig. 2. Determination of the oligomeric structure of rec-Hspl2.2 
and rec-Hspl2.3. A: Elution profile of purified rec-Hspl2.3 on a 
Sephacryl S-200 HR column. Arrowheads indicate the elution posi- 
tions of molecular mass markers. B: Western blot of rec-Hspl2.3 
after crosslinking by bis(sulfosuccinimidyl)suberate, in the absence 
(lane 1) or presence (lane 2) of BSA. Positions of molecular mass 
markers are indicated. C: Elution profile of rec-Hspl2.2 on a Super- 
ose 12 column after crosslinking by dimethylsuberimidate. The in- 
sert shows the SDS-PAGE pattern of fractions 30-34, stained with 
Coomassie brilliant blue. 
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Fig. 3. Chaperone assays of rec-Hspl2.2 and rec-Hspl2.Y A, B: 
Reduction-induced aggregation of insulin B-chain at 40°C as a func- 
tion of time in the presence and absence of various amounts of rec- 
Hspl2.2 (A) and rec-Hspl2.3 (B) and 0tB-crystallin. sHSP to insulin 
mass ratios are indicated. C: Temperature-induced aggregation of 
citrate synthase at 43°C in the absence and presence of rec-Hspl2.2, 
rec-Hspl2.3 and c~B-crystallin. 
Hspl2.3 largely occur as tetramers, probably in slow equili- 
brium with trimers, dimers and/or monomers. 
3.3. Rec-Hspl2.2 and rec-Hspl2.3 lack chaperone-like activity 
In view of the relatively lower heat stability of rec-Hspl2.2 
as compared with rec-Hspl2.3, we could not perform the 
original heat-protection chaperone assay at 58°C [5]. How- 
ever, the reduction-induced aggregation of insulin, performed 
at 40°C [23], appeared not to be prevented by the presence of 
up to 100 300% mass ratios of rec-Hspl2.2 or rec-Hspl2.3 to 
insulin (Fig. 3A,B, respectively). In contrast, at a 100% mass 
ratio, ~B-crystallin provided complete protection. To confirm 
the apparent lack of chaperone-like capacity of rec-Hspl2.2 
and rec-Hspl2.3, we also tested their ability to prevent the 
aggregation of thermally unfolding citrate synthase, per- 
formed at 43°C [6]. Again, the presence of an excess of rec- 
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Hspl2.2 or rec-Hspl2.3 did not prevent the aggregation of 
citrate synthase, whereas c~B-crystallin was very effective 
(Fig. 3C). 
3.4. Lessons from rec-H~pl2.2 and rec-H3pl2.3 
Rec-Hspl2.2 and rec-Hspl2.3 are the first sHSPs reported 
to occur as tetramers, while not forming larger complexes. 
Tetrameric and dimeric arrangements have earlier been impli- 
cated as building blocks for larger sHSP complexes. Calori- 
metric studies proposed a dimer structure as the minimum 
cooperative subunit of mammalian Hsp25 [24]. The isolated 
C-terminal domain-with-tail of e~A-crystallin assembles into 
tetramers, and also resembles rec-Hspl2.2 and 12.3 in that 
it lacks chaperone activity [20]. Moreover, in the presence of 
1% deoxycholate, ~A-crystallin complexes dissociate into 80 
kDa tetramers, without altering the secondary and tertiary 
structure [25]. Based on tetrameric building blocks, a rhom- 
bododecahedral model, with two-, three- and fourfold symme- 
tries, has been proposed for c~-crystallin [26]. In light of the 
most recent X-ray [15] and cryo-EM [16] data, we can envis- 
age that tetrameric building blocks, as exemplified by the 12 
kDa sHSPs, form the wall of a cage. The more hydrophobic 
N-terminal domains are likely to provide the necessary inter- 
active surfaces to assemble the higher order complexes. 
It is tempting to attribute the inability of rec-Hspl2.2 and 
rec-Hspl2.3, as well as the ~A-crystallin C-terminal domain- 
with-tail, to form larger complexes than tetramers, to the near 
or complete absence of an N-terminal domain. Also for C 
elegans rec-Hspl6.2, it has been observed that shortening of 
the N-terminal domain by 15 residues - which gives its N- 
terminal domain the same length as that of the Hspl2 family 
- abrogates its ability to form large multimeric omplexes [13]. 
It thus appears that an N-terminal domain of sufficient length 
is generally required for sHSP multimerization. It is of interest 
that C. elegans Hspl2.6, which is 48 and 67% identical to 
Hspl2.2 and 12.3, respectively, did not seem to form oligom- 
ers, but rather was considered to be monomeric based on 
sedimentation velocity data [18]. It may well be that the equi- 
librium between mono- and oligomers is not positioned 
equally for all rec-Hspl2 members, and that only a very small 
fraction of rec-Hspl2.6 forms di- and tetramers (see Fig. 5, 
lane 1 in [18]). It is also possible that the crosslinking effi- 
ciency of different family members could be variable, resulting 
in a lesser degree of crosslinking for rec-Hspl2.6, especially at 
lower concentrations of the protein. 
The properties of rec-Hspl2.2, rec-Hspl2.3 and the C-ter- 
minal domain-with-tail of c~A-crystallin, as well as the trun- 
cation mutants of C elegans Hspl6-2 all indicate, too, that 
higher complex formation, beyond the tetramer, is also re- 
quired for chaperone-like activity. This may agree with the 
observation that only the large complexes of Hsp25/Hsp27 
are able to confer in vivo protection against oxidative stress 
[27,28]. Although the sites of interaction of unfolded sub- 
strates with sHSPs are likely to be within or very close to 
the conserved c~-crystallin domain [7,29], the N-terminal do- 
main has also been implicated in substrate binding [14]. In 
addition to accessible hydrophobic binding sites, it appears 
that the presence of flexible polar C-terminal extensions im- 
proves the chaperone capacity of sHSPs by enhancing the 
solubility of the sHSP-substrate complex [13,14]. The loss in 
the C elegans Hspl2 family of a sufficiently large N-terminal 
domain, and the absence of a C-terminal tail, would then 
explain both the inability to form larger multimers and the 
lack of in vitro chaperone-like activity. 
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